|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 11 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-12-24 |
4 |
AS |
$88.73 |
$177,462 |
D/D |
(2,000) |
227,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-01-09 |
4 |
AS |
$94.14 |
$188,286 |
D/D |
(2,000) |
225,157 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-28 |
4 |
OE |
$14.39 |
$32,250 |
D/D |
2,000 |
288,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-12-12 |
4 |
AS |
$93.12 |
$186,240 |
D/D |
(2,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-12-12 |
4 |
OE |
$17.86 |
$35,720 |
D/D |
2,000 |
290,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-12-14 |
4 |
AS |
$92.64 |
$185,280 |
D/D |
(2,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-12-14 |
4 |
OE |
$17.86 |
$35,720 |
D/D |
2,000 |
290,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-10 |
4 |
S |
$114.89 |
$232,201 |
I/I |
(2,021) |
36,258 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-04-30 |
4 |
AB |
$10.37 |
$21,248 |
D/D |
2,049 |
6,120 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,144 |
12,988 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2008-12-05 |
4 |
B |
$1.72 |
$4,058 |
D/D |
2,300 |
31,722 |
2.31 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-05-12 |
4 |
D |
$121.09 |
$284,440 |
D/D |
(2,349) |
240,826 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2023-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,370 |
425,112 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-11-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,400 |
230,768 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-06-14 |
4 |
B |
$13.15 |
$33,090 |
D/D |
2,500 |
27,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-04 |
4 |
AS |
$18.38 |
$45,962 |
D/D |
(2,500) |
13,195 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-25 |
4 |
AS |
$17.65 |
$44,125 |
D/D |
(2,500) |
10,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-01-26 |
4 |
OE |
$19.75 |
$49,375 |
D/D |
2,500 |
47,940 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2012-06-04 |
4 |
A |
$10.10 |
$25,250 |
D/D |
2,500 |
6,725 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,505 |
15,493 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-30 |
4 |
AB |
$6.92 |
$17,664 |
D/D |
2,553 |
17,695 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-08-14 |
4 |
S |
$7.18 |
$18,991 |
D/D |
(2,621) |
24,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-04 |
4 |
S |
$25.84 |
$70,547 |
D/D |
(2,700) |
88,193 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-10-31 |
4 |
B |
$6.92 |
$19,103 |
D/D |
2,761 |
33,642 |
2.81 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2008-05-21 |
4 |
B |
$3.53 |
$10,619 |
D/D |
3,000 |
27,821 |
2.39 |
- |
|
850 Records found
|
|
Page 11 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|